Dir., President and Chief Executive Officer at Syros Pharmaceuticals, Inc.
Nancy Simonian, M.D. has been our chief executive officer since July 2012. From 2001 to October 2011, Dr. Simonian was employed by Takeda Pharmaceuticals Company, a publicly-held biopharmaceutical company, and at Millennium Pharmaceuticals, Inc. prior to its acquisition by Takeda, most recently as chief medical officer and senior vice president of clinical, medical and regulatory affairs. From 1995 to 2001, Dr. Simonian served at Biogen, Inc., a publicly-held biotechnology company, most recently as vice president of clinical development. She is a member of the boards of directors of Seattle Genetics, Inc., a biotechnology company, the Damon R ...
Source: Syros Pharmaceuticals, Inc. on 04/26/2018
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Nancy A. Simonian M.D.. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: Nancy A. Simonian M.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.